Gold falls to near $4,050 amid US- Iran talks uncertainty
Gold price (XAU/USD) attracts some sellers to around $4,060 during the Asian trading hours on Monday. The precious metal declines amid uncertainty surrounding US-Iran talks and hawkish Federal Reserve (Fed) expectations. The US Nonfarm Payrolls (NFP) data will take center stage later on Thursday.
The United States (US) and Iran agreed to halt attacks and plan to meet in Doha, Qatar, on Tuesday to resolve their dispute over the Strait of Hormuz, Axios reported. US officials stated that Washington and Tehran “will stand down for now” following an exchange of fire near the critical waterway over the last several days.
However, uncertainty remains high as Iran’s Foreign Minister Abbas Araghchi said that responsibility for the Strait of Hormuz lies solely with Tehran. An Iranian official warned that any attempt to bypass its preferred route in the waterway will cause “tension and escalation.” Any signs of rising tensions in the Middle East could raise inflation worries, prompting traders to raise their bets on rate hikes and weighing on the non-yielding bullion.
Traders are now pricing in nearly a 59.7% chance of a rate hike as early as September 2026, according to the CME FedWatch Tool. The upcoming NFP and labor market reports on Thursday will offer some hints about the US interest rate path. Economists forecast an increase of 114,000 jobs in June and the Unemployment Rate holding steady at 4.3% during the same period.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
